Request a Report
Request a Demo

Truvada Update:
Rx Considerations When Underwriting HIV, PrEP and PEP

This webinar was featured live in June 2018. Please register to view the recording.

Register

In this 60-minute, complimentary webinar, you’ll learn about important considerations when underwriting HIV, PrEP, and PEP using prescription histories.

Topics covered

  • HIV overview
  • Transmission and epidemiology
  • Therapy specifics
  • Regulatory landscape
  • Interpreting Truvada risk

Who should attend

This session is intended for medical directors, underwriters, and other life and clinical professionals at insurance companies.

Presenter

Dan Fleischman, PharmD, BCPS

Manager, Clinical Services, Milliman IntelliScript

You might also enjoy

Read More

The Wondrous Dichotomy: Filtering High-morbidity Applicants AND Issuing More Business with Medical Claims Data

Read More

Revealing the insurable market in severe obesity: new research challenges the status quo

Read More
Your choices regarding cookies on this site
Logo

This website uses cookies to provide you with an optimized experience. Refer to our privacy policy for more information regarding our use of data or click here to learn more about the cookies we use and how to disable them.

Required Cookies

These Cookies are necessary for you to access and navigate our sites.

Analytics & Performance

These Cookies are used by us or third-party service providers to analyze how the Sites are used and how they are performing. We use the following service providers and you can learn more about their privacy policies and how to opt-out of their cookies by clicking on these links: